|
Study Site Monitoring
- Investigator Selection and Pre-Initiation Qualification
- Study Site Initiation and Regulatory Document Collection
- Investigator Meetings and/or Investigational Site Training
- Periodic Site Monitoring, Including Source Document Auditing, Compliance With
GCPs, and
Drug Accountability
- Data Review, Rectification, and Resolution
- Adverse Event Documentation and Reporting
- Close-out Study Site Visits and Study Termination
- Preparing a Study Site for a Regulatory Inspection
|
|
Send mail to Michael Gendron, Ph.D.
with questions
or comments about this web site.
Copyright © 1997-2000 Precision Research, Inc.
Last modified: November 28, 2000
This web site is optimized for Microsoft Internet Explorer,
and best viewed at a resolution of 800x600.
|